Patients with renal, endometrial, colorectal, and pancreatic cancer concomitant with high TNNT1 expression have an unfavorable prognosis compared to patients with low TNNT1 expression (Figure 3). The gene discussed is TNNT1; the disease is familial pancreatic carcinoma.